ArticleJournal for immunotherapy of cancer2019

α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas.

E Dodagatta-Marri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.